SARS-CoV-2 MRNA Vaccine

SARS-CoV-2 MRNA Vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.

The CVnCov Vaccine (or CV07050101) is in development by CureVac AG. The vaccine uses mRNA technology to create a protein associated with SARS-CoV2, and upon administration and replication, to initiate subsequent immune responses in the body. As of June 2020, the company received regulatory approval from German and Belgian Authorities to commence Phase 1 clinical trials of this vaccine (NCT04449276).

Trade Name SARS-CoV-2 MRNA Vaccine
Generic CVnCoV
CVnCoV Other Names CV07050101, SARS-CoV-2 mRNA vaccine
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
SARS-CoV-2 MRNA Vaccine
SARS-CoV-2 MRNA Vaccine

Innovators Monograph

You find simplified version here SARS-CoV-2 MRNA Vaccine


*** Taking medicines without doctor's advice can cause long-term problems.
Share